Novo Nordisk As Stock Alpha and Beta Analysis
| NVO Stock | USD 135.28 2.48 1.87% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Novo Nordisk AS. It also helps investors analyze the systematic and unsystematic risks associated with investing in Novo Nordisk over a specified time horizon. Remember, high Novo Nordisk's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Novo Nordisk's market risk premium analysis include:
Beta 0.87 | Alpha 0.13 | Risk 1.77 | Sharpe Ratio 0.0464 | Expected Return 0.0823 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Novo |
Novo Nordisk Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Novo Nordisk market risk premium is the additional return an investor will receive from holding Novo Nordisk long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Novo Nordisk. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Novo Nordisk's performance over market.| α | 0.13 | β | 0.87 |
Novo Nordisk expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Novo Nordisk's Buy-and-hold return. Our buy-and-hold chart shows how Novo Nordisk performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Novo Nordisk Market Price Analysis
Market price analysis indicators help investors to evaluate how Novo Nordisk stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Novo Nordisk shares will generate the highest return on investment. By understating and applying Novo Nordisk stock market price indicators, traders can identify Novo Nordisk position entry and exit signals to maximize returns.
Novo Nordisk Return and Market Media
The median price of Novo Nordisk for the period between Sat, Mar 2, 2024 and Fri, May 31, 2024 is 128.31 with a coefficient of variation of 3.24. The daily time series for the period is distributed with a sample standard deviation of 4.16, arithmetic mean of 128.34, and mean deviation of 3.47. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
| Novo Nordisk dividend paid on 2nd of April 2024 | 04/02/2024 |
1 | Generics Player Teva Pharmaceutical Aces Late-Stage Schizophrenia Drug Study, Stock Shoots Higher | 05/08/2024 |
2 | What the results of Wegovys longest clinical trial yet show about weight loss, side effects and heart protection | 05/13/2024 |
3 | Novo Nordisks Once-Weekly Insulin Flagged With Risk Of Low Blood Sugar Ahead Of FDA Review | 05/22/2024 |
4 | The Zacks Analyst Blog Highlights Stocks recently featured in the blog include Novo Nordisk, Qualcomm, Caterpillar, CSP and Epsilon Energy | 05/23/2024 |
5 | Weight-loss drugs reduce kidney complication risks Study | 05/24/2024 |
6 | Supplies of Wegovy and Other Weight Loss Drugs Can Now Be Tracked by Patients | 05/29/2024 |
About Novo Nordisk Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Novo or other stocks. Alpha measures the amount that position in Novo Nordisk AS has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0127 | 0.0119 | 0.0101 | 0.0178 | Price To Sales Ratio | 12.0 | 12.04 | 13.48 | 14.16 |
Novo Nordisk Upcoming Company Events
As portrayed in its financial statements, the presentation of Novo Nordisk's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Novo Nordisk's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Novo Nordisk's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Novo Nordisk. Please utilize our Beneish M Score to check the likelihood of Novo Nordisk's management manipulating its earnings.
| 31st of January 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 31st of January 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Novo Nordisk
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Novo Nordisk Backtesting, Novo Nordisk Valuation, Novo Nordisk Correlation, Novo Nordisk Hype Analysis, Novo Nordisk Volatility, Novo Nordisk History and analyze Novo Nordisk Performance. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Novo Stock analysis
When running Novo Nordisk's price analysis, check to measure Novo Nordisk's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Nordisk is operating at the current time. Most of Novo Nordisk's value examination focuses on studying past and present price action to predict the probability of Novo Nordisk's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Nordisk's price. Additionally, you may evaluate how the addition of Novo Nordisk to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |
Novo Nordisk technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.